AccuSift provides high-performance 3-Methylquinoxaline-2-carboxylic acid (MQCA) competitive assay pairings, characterized by exceptional batch-to-batch consistency and optimized for IVD kit development (Lateral Flow, Chemiluminescence, ELISA, POCT). These pairings offer high affinity and specificity, facilitating rapid detection.3-Methylquinoxaline-2-carboxylic acid (MQCA) is the primary metabolite of Olaquindox in animals, serving as a marker residue for monitoring Olaquindox residues. MQCA features a quinoxaline ring core with a carboxyl group at the 2-position and a methyl group at the 3-position. Compared to the parent drug, MQCA has a longer residual period in animal tissues, making it more suitable for regulatory monitoring. Olaquindox and its metabolites possess cumulative toxicity, genotoxicity, and teratogenic risks, leading to their prohibition in food-producing animals in China.Performance Characteristics:
Sensitivity: ELISA IC50: 1 ppb; Colloidal Gold: 0.5-1 ppb
Source: Mouse Monoclonal Antibody
Recommended Pairing: (Coating) / (Labeling)
Storage: Long-term storage at ≤ –20°C; short-term storage at 2–8°C. Shipped on ice packs.